Publications by authors named "David Matheson"

Claim this Profile
M
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Silke Gillessen, Laura Murphy, Nicholas D James, Ashwin Sachdeva, Omar El-Taji, David Matheson

Lancet Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inventory of self-assessed competences: a tool for identifying training strengths and weaknesses in medical and multiprofessional residency programmes for primary health care.
Élida de Fátima Diniz Souza, Ana Paula Ramos Machado, José Danúzio Leite de Oliveira, José Olivandro Duarte de Oliveira, Lauradella Geraldinne Sousa Nóbrega, David Matheson

BMC Med Educ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-care practices of professionals on residency programs in the state of Paraíba in Brazil and their implications for primary health care.
Ana Paula Ramos Machado, Élida de Fátima Diniz Souza, José Danúzio Leite de Oliveira, José Olivandro Duarte de Oliveira, Lauradella Geraldinne Sousa Nóbrega, David Matheson

BMC Prim Care· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC).
Silke Gillessen, Fabio Turco, Ian D Davis, Jason A Efstathiou, Karim Fizazi, David Matheson

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Can Participant Experience of Quality-of-Life Research Be Improved in Cancer Research: Views of the Patient and Public Involvement Representatives from the STAMPEDE2 Prostate Cancer Trial.
Minal Padden-Modi, Hannah Rush, Hoda Abdel-Aty, David Matheson, Robin Millman

Eur Urol Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Theory-Practice Gap in the Education of Biomedical Scientists.
Kathryn Dudley, David Matheson

Br J Biomed Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Claire L Vale, David J Fisher, Peter J Godolphin, Larysa H Rydzewska, Jean-Marie Boher, David Matheson

Lancet Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022.
Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, David Matheson

Eur J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life Measurements from the Patient Perspective: Capturing the Heterogeneity of the Patient Experience in a Standardised Way.
David Matheson, Hoda Abdel-Aty, Lorna O'Shea

Eur Urol Focus· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, Ashwin Sachdeva, Craig Jones, David Matheson

Lancet Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Silke Gillessen, Alberto Bossi, Ian D Davis, Johann de Bono, Karim Fizazi, David Matheson

Eur Urol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional differences regarding the occurrence of falls and associated factors in two populations of Brazilian longevous people.
Jaíza M M Silva, Javanna Lacerda Gomes da Silva Freitas, Júlia Cristina Leite Nóbrega, Juliana Barbosa Medeiros, Raisa Fernandes Mariz Simões, David Matheson

BMC Geriatr· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of distance and transportation in decision making to seek emergency obstetric care among women of reproductive age in south-South Nigeria: A mixed methods study.
Mandu S Ekpenyong, David Matheson, Laura Serrant

Int J Gynaecol Obstet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Nicholas D James, Noel W Clarke, Adrian Cook, Adnan Ali, Alex P Hoyle, David J Matheson

Int J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.
Nicholas D James, Fiona C Ingleby, Noel W Clarke, Claire L Amos, Gerhardt Attard, David J Matheson

JNCI Cancer Spectr· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
Caroline S Clarke, Rachael M Hunter, Andrea Gabrio, Christopher D Brawley, Fiona C Ingleby, David Matheson

PLoS One· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
Chris C Parker, Nicholas D James, Christopher D Brawley, Noel W Clarke, Adnan Ali, David Matheson

PLoS Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-Related Quality of Life and Associated Factors: Regional Differences Among Oldest-Old in Brazil.
Javanna L G da S Freitas, Jaíza M M Silva, Júlia Cristina L Nóbrega, Raisa F M Simões, Juliana B Medeiros, David Matheson

Inquiry· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life in Men With Prostate Cancer Randomly Allocated to Receive Docetaxel or Abiraterone in the STAMPEDE Trial.
Hannah L Rush, Laura Murphy, Alicia K Morgans, Noel W Clarke, Adrian D Cook, David Matheson

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychosocial aspects and support networks associated with disability in two longevous populations in Brazil: a cross-sectional study.
Júlia Cristina Leite Nóbrega, Juliana Barbosa Medeiros, Javanna Lacerda Gomes da Silva Freitas, Jaíza M M Silva, Raisa Fernandes Mariz Simões, David Matheson

BMC Geriatr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Gerhardt Attard, Laura Murphy, Noel W Clarke, William Cross, Robert J Jones, David Matheson

Lancet· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic Factors and Health Status Disparities Associated with Difficulty in ADLs and IADLs among Long-Lived Populations in Brazil: A Cross-Sectional Study.
Júlia Cristina Leite Nóbrega, Juliana Barbosa Medeiros, Tácila Thamires de Melo Santos, Saionara Açucena Vieira Alves, Javanna Lacerda Gomes da Silva Freitas, David Matheson

Inquiry· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abiraterone in "High-" and "Low-risk" Metastatic Hormone-sensitive Prostate Cancer.
Alex P Hoyle, Adnan Ali, Nicholas D James, Adrian Cook, Christopher C Parker, David Matheson

Eur Urol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevention of arboviral diseases using mobile devices: a preliminary study of the attitudes and behaviour change produced by educational interventions.
Francisco Fernandes Abel Mangueira, Roberta Smania-Marques, Izabelly Dutra Fernandes, Victor Alves Albino, Ricardo Olinda, David Matheson

Trop Med Int Health· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness.
Beth S Woods, Eleftherios Sideris, Matthew R Sydes, Melissa R Gannon, Mahesh K B Parmar, David Matheson

Eur Urol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis